Treatment of unresectable intrahepatic cholangiocarcinoma with yttrium-90 radioembolization: a systematic review and pooled analysis.
Al-Adra, D P; Gill, R S; Axford, S J; Shi, X; Kneteman, N; Liau, S-S.
Eur J Surg Oncol
; 41(1): 120-7, 2015 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-25449754
Comparative effectiveness of hepatic artery based therapies for unresectable intrahepatic cholangiocarcinoma.
Integration of chemoembolization and radioembolization into multimodal treatment of cholangiocarcinoma.
Intra-arterial yttrium-90 radioembolization combined with systemic chemotherapy is a promising method for downstaging unresectable huge intrahepatic cholangiocarcinoma to surgical treatment.
18F-FDG PET independently predicts survival in patients with cholangiocellular carcinoma treated with 90Y microspheres.
Multimodality treatment of intrahepatic cholangiocarcinoma: A review.
Yttrium-90 Radioembolization for Hepatocellular Carcinoma Prior to Liver Transplantation.
Transcatheter intraarterial therapies: rationale and overview.
Yttrium-90 Radioembolization for Unresectable Combined Hepatocellular-Cholangiocarcinoma.
PET response criteria for solid tumors predict survival at three months after intra-arterial resin-based 90Yttrium radioembolization therapy for unresectable intrahepatic cholangiocarcinoma.
Yttrium-90 microsphere radioembolisation for unresectable hepatocellular carcinoma.